Introduction
Common Neuropsychiatric Disorders (NPDs) are a major cause of morbidity and impairments in the quality of life around the world, 1 with very large societal costs in the order of trillions of dollars. 2 Several common NPDs (such as schizophrenia, bipolar disorder, Alzheimer's disease) have large heritabilities, with a possible shared pathophysiology for some of them, highlighting the importance of the study of genetic factors. 3, 4 In recent years, dozens of genome-wide association studies (GWASs) have been carried out for NPDs. [5] [6] [7] However, very few consistent and strong associations with NPDs have been found. 3, 8 GWASs have been based in the common disease/common variant (CDCV) hypothesis. This hypothesis proposes that a single common variant could be a risk factor for a large fraction of patients. 9 Several researchers have proposed that an alternative hypothesis, the common disease/rare variants (CDRV) could lead to the identification of additional risk factors for complex diseases, such as neuropsychiatric disorders. 9 In the context of the CDRV hypothesis, a special interest is focused on functional variants, such as nonsynonymous SNPs (nsSNPs), which are a minor fraction of the total number of SNPs. nsSNPs represent the most well understood group of genetic variants of possible functional importance. 10 Alterations in dozens of genes involved in brain plasticity are responsible for increasing or decreasing the risk of NPDs. [6] [7] [8] [11] [12] [13] In the present study, we screened in silico a large number of brain-expressed genes, identified 5 nsSNPs located in genes of neuropsychiatric relevance, developed novel genotyping assays and reported their frequencies in a sample of Colombian healthy subjects. 
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Genotyping of nsSNPs
DNA samples, extracted from peripheral blood using a salting out method, 23 from 171 unrelated Colombian subjects (122 women; mean age = 21.2; SD = 2.92) were genotyped for the 5 nsSNPs. None of the subjects had personal history of neuropsychiatric disorders. Written informed consent was obtained from all subjects and this study was approved by the institutional ethical committee 24 and was conducted according to the Declaration of Helsinki Principles. Table III for primers concentrations). PCR products were separated in a 2% agarose gel, stained with SYBR Safe (Invitrogen, Carlsbad, CA, USA) and visualized on a UV Transilluminator. Genotyping process for NPAS2 gene was carried out in a CFX96 Touch Real-Time PCR system (BioRad, Hercules, CA, USA). To verify the consistency in the genetic results, a random subsample (10% of subjects) was re-genotyped for each nsSNP. In addition, two different investigators confirmed and validated the results, independently checking all genotypes.
Conventional PCR (AS-PCR and T-ARMS-PCR
NPAS2-rs2305160 was analyzed using a specific TaqMan SNP Genotyping Assay (Applied Biosystems, Foster City, CA, USA). It was performed as follows: 2 μl (20 ng) genomic DNA, 1 X TaqMan ® Genotyping Master Mix (Applied Biosystems), 1 X of TaqMan Pre-Designed SNP Genotyping Assay (C__15976652_10, Applied Biosystems) and water in a total volume of 10 μl. The amplification protocol consisted of 10-min denaturation step at 95°C (1 cycle), 95°C for 15s and 60°C for 90s (50 cycles).
Statistical analysis
PLINK program was used for Hardy-Weinberg equilibrium analysis of genotype and allele frequencies. 25 Allele frequencies for the five nsSNPs were compared using a 2 × 2 contingency table between Colombian subjects and HapMap samples: Utah Residents with Northern and Western European ancestry (CEU); Yoruba in Ibadan, Nigeria (YRI); Han Chinese in Bejing, China (CHB); Japanese in Tokyo, Japan (JPT); and Mexican ancestry from Los Angeles, USA (MXL). Results were considered statistically significant at p<0.05
Results
An in silico screening of several dozens of human brain-expressed genes identified 5 nsSNPs (rs6855837; p.Leu395Ile, rs2305160; p.Thr394Ala, rs10503929; p.Met289Thr, rs2270641; p.Thr4Pro and rs3822659; p.Ser735Ala), with higher probabilities of being true positives (MAF>0.01 in HapMap samples) ( Table 2 ). These nsSNPs are located in genes (CLOCK, NPAS2, NRG1, SLC18A1 and WWC1) with a high relevance for neuropsychiatric disorders and endophenotypes (Table 1) , supported by multiple lines of experimental evidence, such as genome-wide expression and association studies and meta-analysis of genetic association studies.
We designed novel cost-effective genotyping assays, based in allele-specific PCR methods, for four of these nsSNPs (Table 3) . We genotyped these five nsSNPs in a sample of healthy subjects (CLB). Table 4 shows the allele and genotype frequencies We compared MAFs for these five nsSNPs found in the Colombian population with available data for samples from European, African, Asian and Latin American populations (extracted from HapMap). The YRI samples was the only population with significant differences for all genetic markers, with a p value less than 0.01 (see Figure 1) . For CHB and JPT samples, we observed significant differences for rs10503929 (NRG1) and rs3822659 (WWC1) SNPs (p<0.002). Finally, the CLB samples showed allelic frequencies similar to those of MEX and CEU samples for all SNPs, with only one exception, rs6855837 SNP (MEX p = 0.039 and CEU p<0.001).
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Discussion
Alterations in dozens of genes involved in brain and synaptic plasticity are responsible for a large number of common NPDs. [11] [12] [13] 26 Genome-wide association studies, mainly focused on non-functional SNPs, have found a few consistent and strong associations with NPDs.
3 nsSNPs represent the most well understood group of genetic variants of possible functional importance. 10 Due to their impact on function of the encoded proteins, nsSNPs are not common in brain-expressed genes. 10 We identified five nsSNPs in brain-expressed genes of high relevance for neuropsychiatric disorders: CLOCK, NRG1, NPAS2, SLC18A1 and WWC1. CLOCK is a key regulator of the circadian system, and regulates the transcription of PER1, PER2, PER3, CRY1 and CRY2 genes. NRG1 is known to mediate cell-cell interactions in the nervous system and has been implicated in the etiology of schizophrenia.
27 NPAS2 also has a key role the regulation of circadian mechanisms in the brain.
28 SLC18A1 encodes the vesicular amine transporter 1 (also known as VMAT1), important for the functioning of monoaminergic systems. 29 WWC1 is involved in long-term potentiation mechanisms and synaptic plasticity. 30 There is previous experimental evidence, arising from genome-wide expression and association studies, implicating the involvement of these genes in several neuropsychiatric disorders and endophenotypes, such as schizophrenia, mood disorders or memory performance. [27] [28] [29] [30] However, a large part of the previously studied variants in these genes were neutral polymorphisms. 5 Similary the SNP detection method has wide applications and can be used for diagnosis of other untreated neurodegenerative disorders such as ALS, Parkinson's and AMD as shown. [31] [32] [33] [34] [35] [36] [37] Cost-effective genotyping assays described in this work for these nsSNPs could be interesting methodological alternatives for researchers in developing and developed countries. These five nsSNPs in brain-expressed genes represent interesting candidates to analyze in future genetic studies of neuropsychiatric disorders and related endophenotypes, a focused synaptogenomics approach. 
